Menu

Treace Medical Concepts, Inc. TMCI

Full chart Compare
Set alert

Price alert · TMCI

All alert types
4.03 USD -0.15 (-3.59%)

At closeNov 6, 2026, 4:25 PM EST

4.11 +0.08 +1.99%

After hours · Nov 6, 4:25 PM ET

3.42 Day range 4.23
1.20 52-week range 6.23
YTD
+64.49%
1 year
-35.31%

Revenue & Expenses

Other Income → Expenses: $472.00KExpenses → Selling, General & Admin: $203.62MExpenses → Research & Development: $20.28MExpenses → Interest Expense: $5.32MGross Profit → Expenses: $169.75MRevenue → Gross Profit: $169.75MRevenue → Cost of Revenue: $42.94MNet Loss → Expenses: $59.00MOther Income$472.00KGross Profit$169.75MNet Loss$59.00MCost of Revenue$42.94MExpenses$229.23MSelling, General & Admin$203.62MResearch & Development$20.28MInterest Expense$5.32MRevenue$212.69M

Latest period ending Dec 31, 2025 · select a line to chart its full history

TMCI annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
212.69M209.36M187.12M141.84M94.42M
169.75M168.26M151.94M116.31M77.53M
-54.15M-55.69M-51.43M-34.84M-16.51M
-59.00M-55.74M-49.53M-42.81M-20.55M
-0.93-0.90-0.81-0.77-0.43
TMCI annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
10.71M11.35M12.98M19.47M105.83M
190.58M217.09M251.91M159.02M140.82M
103.25M104.20M113.97M98.50M47.75M
69.56M69.24M68.90M68.25M29.36M
87.33M112.89M137.94M60.53M93.07M
TMCI annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-15.97M-37.17M-34.58M-30.65M-17.19M
13.25M35.38M-81.30M-76.52M-2.71M
2.08M160.00K109.38M20.81M107.65M
-13.52M-11.59M-11.46M-14.84M-2.71M
-642.00K-1.63M-6.49M-86.36M87.75M